Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PH-797804 in adults with moderate to severe COPD on background salmeterol/fluticasone
2010-024219-15Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2011
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing PH-797804 plus background therapy with Placebo plus background therapy (2 arms). Primary endpoint: Primary efficacy endpoint. Started Mar 2011; status: completed.
02
Drugs
PH-797804
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2010-024219-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024219-15.